BI
ABBV icon

Bramshill Investments’s AbbVie ABBV Stock Holding History

Bramshill Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-274
Closed -$40.6K – 125
2023
Q4 		$40.6K Hold
274
– – ﹤0.01% 164
2023
Q3 		$40.6K Sell
274
-18
-6% -$2.64K ﹤0.01% 122
2023
Q2 		$40K Sell
292
-11,946
-98% -$1.75M ﹤0.01% 139
2023
Q1 		$1.95M Buy
12,238
+166
+1% +$25.4K 0.23% 50
2022
Q4 		$1.95M Buy
+12,072
New +$1.85M 0.23% 54
2020
Q4 		– Sell
-8,945
Closed -$783K – 145
2020
Q3 		$783K Buy
8,945
+128
+1% +$12.1K 0.11% 57
2020
Q2 		$866K Buy
8,817
+216
+3% +$19K 0.14% 59
2020
Q1 		$655K Buy
+8,601
New +$733K 0.12% 81

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bramshill Investments's ABBV Position: Q1 2024 in Review

Bramshill Investments sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 274 shares — an estimated $40.6K sold.

Bramshill Investments first reported a position in ABBV in Q1 2020 and held it in 8 quarters. The position peaked at $1.95M in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Bramshill Investments reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Bramshill Investments sold 274 AbbVie shares in Q1 2024, an estimated $40.6K.
  • Bramshill Investments first reported a position in AbbVie in Q1 2020 and held it in 8 quarters.
  • Bramshill Investments's AbbVie position peaked at $1.95M in Q4 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Bramshill Investments's 13F filing for Q1 2024, filed 15 May 2024.